ERBB2 and neoplasm: Some excellent studies have defined tumor subtypes using various methods, such as histopathological classification methods (based on ER, PR, and HER2), gene expression-based classification methods (PAM50) (5), and immunogenomics methods (6), which have been conducive to the identification of novel therapeutic targets.